Exenatide extended release and Pioglitazone and Glimepiride Tablets
Determining the interaction of Exenatide extended release and Pioglitazone and Glimepiride Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using glimepiride together with exenatide can increase the risk of hypoglycemia, or low blood sugar. You may need a dose adjustment or more frequent monitoring of your blood sugar to safely use both medications. Let your doctor know if you experience hypoglycemia during treatment. Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSE: Coadministration of a glucagon-like peptide-1 (GLP-1) receptor agonist with an insulin secretagogue (e.g., sulfonylurea, meglitinide) may potentiate the risk of hypoglycemia. GLP-1 receptor agonists lower blood glucose by stimulating insulin secretion and lowering glucagon secretion.
MANAGEMENT: A lower dosage of the insulin secretagogue may be required when used in combination with a GLP-1 receptor agonist. Blood glucose should be monitored closely, and patients should be counseled to recognize the symptoms of hypoglycemia such as headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, and tachycardia. If hypoglycemia occurs, patients should initiate appropriate remedial therapy immediately and contact their physician. Patients should also be advised to take precautions to avoid hypoglycemia while driving or operating hazardous machinery.
- "Product Information. Trulicity (dulaglutide)." Eli Lilly and Company, Indianapolis, IN.
- "Product Information. Adlyxin (lixisenatide)." sanofi-aventis, Bridgewater, NJ.
- "Product Information. Ozempic (1 mg dose) (semaglutide)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
- "Product Information. Tanzeum (albiglutide)." GlaxoSmithKline, Research Triangle Park, NC.
- "Product Information. Byetta (exenatide)." Amylin Pharmaceuticals Inc, San Diego, CA.
- "Product Information. Victoza (liraglutide)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: Exenatide
Generic Name: glimepiride / pioglitazone
Brand name: Duetact
Synonyms: Glimepiride and pioglitazone, Pioglitazone and Glimepiride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Exenatide extended release-Pioglitazone and metformin
- Exenatide extended release-Pioglitazone and Metformin Extended-Release Tablets
- Exenatide extended release-Pioglitazone and Metformin Tablets
- Exenatide extended release-Pioglitazone Hydrochloride
- Exenatide extended release-Pioglitazone Tablets
- Exenatide extended release-Piperacillin
- Pioglitazone and Glimepiride Tablets-Exenatide Extended-Release Injection (Bydureon BCise)
- Pioglitazone and Glimepiride Tablets-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Pioglitazone and Glimepiride Tablets-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Pioglitazone and Glimepiride Tablets-Exenatide Injection (Byetta)
- Pioglitazone and Glimepiride Tablets-Exenatide Subcutaneous
- Pioglitazone and Glimepiride Tablets-Exfoliating Moisturizer